Cover Image
市場調查報告書

全球兒童用疫苗市場:企業的銷售額與預測

Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis

出版商 iGate Research Pvt Ltd 商品編碼 360471
出版日期 內容資訊 英文 205 Pages
訂單完成後即時交付
價格
Back to Top
全球兒童用疫苗市場:企業的銷售額與預測 Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis
出版日期: 2016年05月03日 內容資訊: 英文 205 Pages
簡介

全球兒童用疫苗市場,由於小孩子的醫療和健全性的重要性相關意識的高漲兒受到推動。

本報告提供全球兒童用疫苗市場相關調查分析,各市場區隔,各地區,各國市場實際成果與預測相關的系統性資訊。

第1章 摘要整理

第2章 全球兒童用疫苗市場與預測

第3章 全球兒童用疫苗市場佔有率與預測

  • 全球兒童用疫苗:各疾病的市場佔有率與預測
  • 全球兒童用疫苗:各企業的市場佔有率與預測
  • 兒童用疫苗企業:各疾病的銷售額佔有率與預測
  • 兒童用各疫苗疾病市場:企業佔有率與預測
  • 全球兒童用疫苗市場:各地區佔有率與預測

第4章 全球兒童用疫苗市場:各疾病分析

  • DTaP (白喉、破傷風、非細胞性百日咳)
  • 小兒麻庳
  • 肝炎
  • 流感
  • HPV (人類乳突病毒)
  • 肺炎球菌
  • 腦膜炎
  • 麻疹、腮腺炎、德國麻疹、水痘 (MMRV)
  • 輪狀病毒
  • Tdap (破傷風、白喉、百日咳)

第5章 全球兒童用疫苗市場:企業分析與策略性聯盟

  • GlaxoSmithKline
  • Sanofi Pasteur
  • Merck
  • Novartis
  • Pfizer
  • bioCSL (現在:Seqirus)
  • Medimmune (AstraZeneca的子公司)

第6章 全球兒童用疫苗:各疾病的企業銷售額與預測

  • GlaxoSmithKline
  • Sanofi Pasteur
  • Merck
  • Novartis
  • Pfizer
  • bioCSL (現在:Seqirus)
  • Medimmune (AstraZeneca的子公司)

第7章 全球兒童用疫苗市場:地理分佈

  • 美國
  • 北美/加勒比海各國
  • 南美
  • 歐洲
  • 日本
  • 印度
  • 中國
  • 其他

第8章 主要疫苗相關的收購

第9章 兒童用疫苗市場:推動因素

第10章 兒童用疫苗市場:課題

圖表

目錄

The growing awareness about the importance of child healthcare and well-being is driving the market for pediatric vaccines globally. Pediatric vaccine continues to be one of the booming segment for the pharmaceutical companies. Pediatric vaccines are used in the prevention of numerous diseases, such as Hepatitis- A and -B. Measles, Influenza, Polio, Tetanus, and Diphtheria. Increasing government and non-government funding for development of vaccine is the major driver for the pediatric vaccine market. The rising incidence of diseases such as influenza, hepatitis and HPV has also fueled the demand for the global pediatric vaccines market. The vaccines industry also faces hindrances such as vaccine safety, shortages and delays, vaccine development time line as well as entry barriers for new manufacturers.

Pediatric Vaccines Market - Disease Wise Analysis

The pneumococcal vaccines accounts for maximum share of the pediatric vaccines market. The DTaP vaccines were the second most popular segment in the year 2015. It is competing closely with MMRV vaccines which controlled XX% share of the pediatric vaccines market in 2015. The rotavirus and influenza vaccines stands at fourth and fifth spots respectively in 2015. While vaccines for Polio, meningococcal and HPV are also gaining ground in pediatric vaccines market landscape.

Pediatric Vaccines Market - Company Analysis

Pfizer is the leading player in the pediatric vaccines market being followed by GSK at the second spot. Merck grabbed the third spot in the Global pediatric vaccines landscape as it provides a wide array of vaccines for various diseases. Sanofi Pasteur and Medimmune stands at the fourth and fifth position respectively in the pediatric vaccines market, while, bioCSl captures least share of the global pediatric vaccines market.

Pediatric Vaccines Market - Disease Wise Company Sales Analysis

GSK and Sanofi Pasteur generates maximum pediatric vaccines revenue from DTaP vaccines. The MMRV vaccines accounts for maximum share of the total Merck pediatric vaccines sales, while, Pfizers main source of pediatric vaccines sales revenue is the pneumococcal vaccines.

Sanofi Pasteur is the dominant player in the DTaP, influenza and meningococcal pediatric vaccines landscape, while in the hepatitis vaccines market, GSK is at the forefront and is expected to maintain its dominancy over a longer period of time. Pfizer is the clear leader in pneumococcal vaccines market. Merck is the leading player in the MMRV and rotavirus vaccines market.

Pediatric Vaccines Market - Regional Distribution

On a regional basis the United States comprises the single largest market for pediatric vaccines being closely followed by Europe. Japans pediatric vaccines market share is expected to remain flat during the forecasting period. China accounts for XX% share of the global pediatric vaccines market in 2015. South America and India are competing closely with each other to grab maximum share of the pediatric vaccines market pie.

iGATE RESEARCH report entitled Pediatric Vaccines Market, Company Sales and Forecast - Global Analysis provides a comprehensive analysis of the fast-evolving high growth vaccines market. This 205 Page report with 116 Figures and 6 Tables has been analyzed from 7 viewpoints:

  • 1. Global Pediatric Vaccines Market - Disease Wise Analysis to 2021
  • 2. Global Pediatric Vaccines Market - Company Sales Analysis and Strategic Alliances
  • 3. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast to 2021
  • 4. Pediatric Vaccines Disease Wise Market - Company Share and Forecast
  • 5. Global Pediatric Vaccines Market - Regional Distribution to 2021
  • 6. Major Vaccines Related Acquisitions (2005-2015)
  • 7. Pediatric Vaccines Market - Driving Factors and Challenges

Global Pediatric Vaccines Market - Disease Wise Analysis to 2021 (10 Disease Analysed)

  • 1. DTaP
  • 2. Polio
  • 3. Hepatitis
  • 4. Influenza
  • 5. HPV
  • 6. Pneumococcal
  • 7. Meningococcal
  • 8. MMRV
  • 9. Rotavirus
  • 10.Tdap

Global Pediatric Vaccines Market - Company Analysis to 2021 (7 Company Analysed)

  • 1. GlaxoSmithKline
  • 2. Sanofi Pasteur
  • 3. Merck
  • 4. Novartis
  • 5. Pfizer
  • 6. bioCSL
  • 7. Medimmune

Global Pediatric Vaccines Market - Geographical Distribution to 2021 (8 Region Analysed)

  • 1. United States
  • 2. North America/Caribbean
  • 3. South America
  • 4. Europe
  • 5. Japan
  • 6. India
  • 7. China
  • 8. Rest of the World

Data Sources

iGATE RESEARCH employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. This report is built by using data and information sourced from Proprietary Information Database, Primary and Secondary Research Methodologies, and In house analysis by iGATE Research dedicated team of qualified professionals with deep industry experience and expertise.

Research Methodologies

Primary Research Methodologies: Questionnaires, Surveys, Interviews with Individuals, Small Groups, Telephonic Interview, etc.

Secondary Research Methodologies: Printable and Non-printable sources, Newspaper, Magazine and Journal Content, Government and NGO Statistics, white Papers, Information on the Web, Information from Agencies Such as Industry Bodies, Companies Annual Report, Government Agencies, Libraries and Local Councils and a large number of Paid Databases.

Table of Contents

1. Executive Summary

2. Global - Pediatric Vaccines Market and Forecast (2010 - 2021)

3. Global - Pediatric Vaccines Market Share and Forecast (2010 - 2021)

  • 3.1 Global Pediatric Vaccines - Disease Wise Market Share and Forecast
  • 3.2 Global Pediatric Vaccines - Company Wise Market Share and Forecast
  • 3.3 Companies Pediatric Vaccines - Disease Wise Sales Share and Forecast
    • 3.3.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share and Forecast
    • 3.3.2 Sanofi Pasteur - Pediatric Vaccines Sales Share and Forecast
    • 3.3.3 Merck - Pediatric Vaccines Sales Share and Forecast
    • 3.3.4 Pfizer - Pediatric Vaccines Sales Share and Forecast
  • 3.4 Pediatric Vaccines Disease Wise Market - Company Share and Forecast
    • 3.4.1 DTaP Pediatric Vaccines - Company Market Share and Forecast
    • 3.4.2 Hepatitis Pediatric Vaccines - Company Market Share and Forecast
    • 3.4.3 Meningococcal Pediatric Vaccines - Company Market Share and Forecast
    • 3.4.4 Pneumococcal Pediatric Vaccines - Company Market Share and Forecast
    • 3.4.5 Rotavirus Pediatric Vaccines - Company Market Share and Forecast
    • 3.4.6 Tdap Pediatric Vaccines - Company Market Share and Forecast
    • 3.4.7 Influenza Pediatric Vaccines - Company Market Share and Forecast
  • 3.5 Global Pediatric Vaccines Market - Region Wise Share and Forecast

4. Global Pediatric Vaccines Market - Disease Wise Analysis

  • 4.1 Diphtheria, Tetanus, Acellular, Pertussis (DTaP) - Pediatric Vaccines Market and Forecast (2006 - 2021)
  • 4.2 Polio - Vaccines Market and Forecast (2006 - 2021)
  • 4.3 Hepatitis - Pediatric Vaccines Market and Forecast (2007 - 2021)
  • 4.4 Influenza - Pediatric Vaccines Market and Forecast (2010 - 2021)
  • 4.5 HPV - Pediatric Vaccines Market and Forecast (2007 - 2021)
  • 4.6 Pneumococcal - Pediatric Vaccines Market and Forecast (2010 - 2021)
  • 4.7 Meningococcal - Pediatric Vaccines Market and Forecast (2010 - 2021)
  • 4.8 Measles, Mumps, Rubella and Varicella (MMRV) - Pediatric Vaccines Market and Forecast (2007 - 2021)
  • 4.9 Rotavirus - Pediatric Vaccines Market and Forecast (2006 - 2021)
  • 4.10 Tdap - Pediatric Vaccines Market and Forecast (2010 - 2021)

5. Global Pediatric Vaccines Market - Company Analysis and Strategic Alliances

  • 5.1 GlaxoSmithKline
    • 5.1.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 5.1.2 Strategic Alliances of GlaxoSmithKline (GSK)
  • 5.2 Sanofi Pasteur
    • 5.2.1 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 5.2.2 Strategic Alliances of Sanofi Pasteur
  • 5.3 Merck
    • 5.3.1 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021)
    • 5.3.2 Strategic Alliances of Merck
  • 5.4 Novartis
    • 5.4.1 Novartis - Pediatric Vaccines Sales (2010 - 2014)
    • 5.4.2 Strategic Alliances of Novartis
  • 5.5 Pfizer
    • 5.5.1 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 5.5.2 Strategic Alliances of Pfizer
  • 5.6 bioCSL (Now Seqirus)
    • 5.6.1 bioCSL - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 5.6.2 Strategic Alliances of bioCSL
  • 5.7 Medimmune (Subsidiary of AstraZeneca)
    • 5.7.1 Medimmune - Pediatric Vaccines Sales and Forecast (2007 - 2021)
    • 5.7.2 Strategic Alliances of Medimmune

6. Global Pediatric Vaccines - Disease Wise Company Sales and Forecast

  • 6.1 GlaxoSmithKline (GSK) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 6.1.1 GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales and Forecast
    • 6.1.2 GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales and Forecast
    • 6.1.3 GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales and Forecast
    • 6.1.4 GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales and Forecast
    • 6.1.5 GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales and Forecast
    • 6.1.6 GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales and Forecast
  • 6.2 Sanofi Pasteur - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 6.2.1 Sanofi Pasteur - DTaP Pediatric Vaccines Sales and Forecast
    • 6.2.2 Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales and Forecast
    • 6.2.3 Sanofi Pasteur - Tdap Pediatric Vaccines Sales and Forecast
    • 6.2.4 Sanofi Pasteur - Influenza Pediatric Vaccines Sales and Forecast
  • 6.3 Merck - Pediatric Vaccines Sales and Forecast (2007 - 2021)
    • 6.3.1 Merck - Hepatitis Pediatric Vaccines Sales and Forecast
    • 6.3.2 Merck - HPV Pediatric Vaccines Sales and Forecast
    • 6.3.3 Merck - MMRV Pediatric Vaccines Sales and Forecast
    • 6.3.4 Merck - Pneumococcal Pediatric Vaccines Sales and Forecast
    • 6.3.5 Merck - Rotavirus Pediatric Vaccines Sales and Forecast
  • 6.4 Pfizer - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 6.4.1 Pfizer - Pneumococcal Pediatric Vaccines Sales and Forecast
    • 6.4.2 Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast
  • 6.5 Novartis - Pediatric Vaccines Sales (2010 - 2014)
    • 6.5.1 Novartis - Influenza Pediatric Vaccines Sales
  • 6.6 bioCSL (Now Seqirus) - Pediatric Vaccines Sales and Forecast (2010 - 2021)
    • 6.6.1 bioCSL - Influenza Pediatric Vaccines Sales and Forecast
  • 6.7 Medimmune (Subsidiary of AstraZeneca) - Pediatric Vaccines Sales and Forecast (2007 - 2021)
    • 6.7.1 Medimmune - Influenza Pediatric Vaccines Sales and Forecast

7. Global Pediatric Vaccines Market - Regional Distribution (2010 - 2021)

  • 7.1 United States - Pediatric Vaccines Market and Forecast
  • 7.2 North America/Caribbean - Pediatric Vaccines Market and Forecast
  • 7.3 South America - Pediatric Vaccines Market and Forecast
  • 7.4 Europe - Pediatric Vaccines Market and Forecast
  • 7.5 Japan - Pediatric Vaccines Market and Forecast
  • 7.6 India - Pediatric Vaccines Market and Forecast
  • 7.7 China - Pediatric Vaccines Market and Forecast
  • 7.8 Rest of the World (ROW) - Pediatric Vaccines Market and Forecast

8. Major Vaccines Related Acquisitions (2005-2015)

9. Pediatric Vaccines Market - Driving Factors

  • 9.1 GAVI Model Fuelling Vaccine Manufacturers
    • 9.1.1 The Partnership Model
    • 9.1.2 The Business Model
  • 9.2 Global Immunization Vision and Strategy (GIVS)
  • 9.3 Growing Vaccine Availability in United States
  • 9.4 The Vaccine Injury Compensation Program
  • 9.5 The Vaccine Safety Data link Project
  • 9.6 Transformation of Vaccine Technologies
  • 9.7 Global Vaccine Action Plan by WHO (2011 - 2020)
  • 9.8 Continuous Focus on Effective Communication Strategies

10. Pediatric Vaccines Market - Challenges

  • 10.1 Hurdles to Optimal use of Licensed Vaccines
    • 10.1.1 Technical Obstacles
    • 10.1.2 Economic obstacles
    • 10.1.3 Cultural Obstacles
  • 10.2 Shortening the Timeline for Vaccine Development
  • 10.3 Complexity of Vaccine Development and Approval System Thwarts Product Development
    • 10.3.1 Legal Obstacles
    • 10.3.2 General Technical Barriers
    • 10.3.3 Economic Barriers
    • 10.3.4 Regulatory Barriers
  • 10.4 Refusal/Resistance to Vaccination
  • 10.5 Vaccine Adverse Event Reporting System
  • 10.6 Vaccine Shortages and Delays
  • 10.7 Obstacles in Vaccine Research and Development
  • 10.8 Barriers to New Entrants in the Vaccines Market

List of Figures:

  • Figure 2-1: Global - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 2-2: Global - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 3-1: Global Pediatric Vaccines - Disease Wise Market Share (Percent), 2010 - 2015
  • Figure 3-2: Global Pediatric Vaccines - Forecast for Disease Wise Market Share (Percent), 2016 - 2021
  • Figure 3-3: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales Share (Percent), 2010 - 2015
  • Figure 3-4: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
  • Figure 3-5: Sanofi Pasteur - Pediatric Vaccines Sales Share (Percent), 2010 - 2015
  • Figure 3-6: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
  • Figure 3-7: Merck - Pediatric Vaccines Sales Share (Percent), 2007 - 2015
  • Figure 3-8: Merck - Forecast for Pediatric Vaccines Sales Share (Percent), 2016 - 2021
  • Figure 3-9: Pfizer - Pediatric Vaccines Sales Share and Forecast (Percent), 2015 - 2021
  • Figure 3-10: DTaP Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015
  • Figure 3-11: DTaP Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
  • Figure 3-12: Hepatitis Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015
  • Figure 3-13: Hepatitis Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
  • Figure 3-14: Meningococcal Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
  • Figure 3-15: Meningococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
  • Figure 3-16: Pneumococcal Pediatric Vaccines - Company Market Share (Percent), 2007 - 2015
  • Figure 3-17: Pneumococcal Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
  • Figure 3-18: Rotavirus Pediatric Vaccines - Company Market Share (Percent), 2006 - 2015
  • Figure 3-19: Rotavirus Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
  • Figure 3-20: Tdap Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
  • Figure 3-21: Tdap Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
  • Figure 3-22: Influenza Pediatric Vaccines - Company Market Share (Percent), 2010 - 2015
  • Figure 3-23: Influenza Pediatric Vaccines - Forecast for Company Market Share (Percent), 2016 - 2021
  • Figure 3-24: Region Wise - Pediatric Vaccines Market Share (Percent), 2010 - 2015
  • Figure 3-25: Region Wise - Forecast for Pediatric Vaccines Market Share (Percent), 2016 - 2021
  • Figure 4-1: DTaP - Pediatric Vaccines Market (Million US$), 2006 - 2015
  • Figure 4-2: DTaP - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-3: Polio - Pediatric Vaccines Market (Million US$), 2006 - 2015
  • Figure 4-4: Polio - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-5: Hepatitis - Pediatric Vaccines Market (Million US$), 2007 - 2015
  • Figure 4-6: Hepatitis - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-7: Influenza - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 4-8: Influenza - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-9: HPV - Pediatric Vaccines Market (Million US$), 2007 - 2015
  • Figure 4-10: HPV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-11: Pneumococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 4-12: Pneumococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-13: Meningococcal - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 4-14: Meningococcal - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-15: MMRV - Pediatric Vaccines Market (Million US$), 2007 - 2015
  • Figure 4-16: MMRV - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-17: Rotavirus - Pediatric Vaccines Market (Million US$), 2006 - 2015
  • Figure 4-18: Rotavirus - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 4-19: Tdap - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 4-20: Tdap - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 5-1: GlaxoSmithKline (GSK) - Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 5-2: GlaxoSmithKline (GSK) - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 5-3: Sanofi Pasteur - Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 5-4: Sanofi Pasteur - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 5-5: Sanofi Pasteur - Pipeline Vaccines, April 2016
  • Figure 5-6: Merck - Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 5-7: Merck - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 5-8: Novartis - Pediatric Vaccines Sales (Million US$), 2010 - 2014
  • Figure 5-9: Pfizer - Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 5-10: Pfizer - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 5-11: bioCSL - Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 5-12: bioCSL - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 5-13: Medimmune - Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 5-14: Medimmune - Forecast for Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-1: GlaxoSmithKline (GSK) - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-2: GlaxoSmithKline (GSK) - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-3: GlaxoSmithKline (GSK) - Hepatitis Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-4: GlaxoSmithKline (GSK) - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-5: GlaxoSmithKline (GSK) - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-6: GlaxoSmithKline (GSK) - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-7: GlaxoSmithKline (GSK) - Rotavirus Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-8: GlaxoSmithKline (GSK) - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-9: GlaxoSmithKline (GSK) - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-10: GlaxoSmithKline (GSK) - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-11: GlaxoSmithKline (GSK) - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-12: GlaxoSmithKline (GSK) - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-13: Sanofi Pasteur - DTaP Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-14: Sanofi Pasteur - Forecast for DTaP Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-15: Sanofi Pasteur - Meningococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-16: Sanofi Pasteur - Forecast for Meningococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-17: Sanofi Pasteur - Tdap Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-18: Sanofi Pasteur - Forecast for Tdap Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-19: Sanofi Pasteur - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-20: Sanofi Pasteur - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-21: Merck - Hepatitis Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 6-22: Merck - Forecast for Hepatitis Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-23: Merck - HPV Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 6-24: Merck - Forecast for HPV Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-25: Merck - MMRV Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 6-26: Merck - Forecast for MMRV Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-27: Merck - Pneumococcal Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 6-28: Merck - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-29: Merck - Rotavirus Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 6-30: Merck - Forecast for Rotavirus Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-31: Pfizer - Pneumococcal Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-32: Pfizer - Forecast for Pneumococcal Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-33: Pfizer - Meningococcal Pediatric Vaccines Sales and Forecast (Million US$), 2015 - 2021
  • Figure 6-34: Novartis - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2014
  • Figure 6-35: bioCSL - Influenza Pediatric Vaccines Sales (Million US$), 2010 - 2015
  • Figure 6-36: bioCSL - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 6-37: Medimmune - Influenza Pediatric Vaccines Sales (Million US$), 2007 - 2015
  • Figure 6-38: Medimmune - Forecast for Influenza Pediatric Vaccines Sales (Million US$), 2016 - 2021
  • Figure 7-1: United States - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-2: United States - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 7-3: North America/Caribbean - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-4: North America/Caribbean - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 7-5: South America - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-6: South America - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 7-7: Europe - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-8: Europe - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 7-9: Japan - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-10: Japan - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 7-11: India - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-12: India - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 7-13: China - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-14: China - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 7-15: ROW - Pediatric Vaccines Market (Million US$), 2010 - 2015
  • Figure 7-16: ROW - Forecast for Pediatric Vaccines Market (Million US$), 2016 - 2021
  • Figure 9-1: US - Number of Retail Clinics offering Vaccination (Number), 2007 - 2012

List of Tables:

  • Table 3-1: Global Pediatric Vaccines - Company Wise Market Share (Percent), 2010 - 2015
  • Table 3-2: Global Pediatric Vaccines - Forecast for Company Wise Market Share (Percent), 2016 - 2021
  • Table 8-1: Worldwide - Major Vaccine Related Acquisitions, (2005 - 2015)
  • Table 9-1: Global - Total Future Deaths Averted through Vaccination (Million), 2011 - 2020
  • Table 9-2: Global Goal-Level Indicators, 2015 & 2020
  • Table 9-3: Improvement Strategies or Requirements - the Joint Commission and the Project's Collaborating Organizations
Back to Top